Otgontuya Altangerel, Jeng Cherng-Jye, Wu Trong-Neng, Chuang Linus T, Shen Jenta
Department of Healthcare Administration, Asia University, Taichung 41354, Taiwan.
Department of Gynecology, Taipei Show Chwan Hospital, 106 Taipei, Taiwan; Department of Obstetrics and Gynecology, Chang-Hua Show Chwan Memorial Hospital, 500009 Changhua County, Taiwan; Department of Obstetrics and Gynecology, School of Medicine, Kaohsiung Medical University, 80756 Kaohiung, Taiwan.
Taiwan J Obstet Gynecol. 2023 Mar;62(2):226-238. doi: 10.1016/j.tjog.2022.11.009.
To compare the treatment efficacies of high-intensity focused ultrasound (HIFU), HIFU combined with gonadotrophin-releasing hormone agonist (GnRH-a), and HIFU combined with GnRH-a and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis. We conducted a literature search in SCIENCE DIRECT, COCHRANE LIBRARY, WILLEY ONLINE LIBRARY, PUBMED, and TAYLOR FRANCIS. A total of 471 articles identified, 12 were included in a systematic review, and 11 of them deemed quantitively eligible included in the meta-analysis. The efficacies of the three treatment regimens were assessed using the dysmenorrhea and menstrual scores at 3, 6, 12, 24 months. Of the three regimens, HIFU combined with GnRH-a and LNG-IUS provides the best outcome. On dysmenorrhea score at 6 months there was significantly different higher heterogeneity with P < 0.00001 (I = 100% WMD 21.44 [6.34, 36.53]) with statistical significance P = 0.005. At 12 months there was significantly different higher heterogeneity P < 0.00001 (I = 100% WMD 23.47 [6.00, 40.94]) with statistically significant P < 0.008. At 24 months there was significantly different higher heterogeneity P < 0.0005 (I = 92% WMD 6.05 [4.81, 7.30]) with statistical significance P < 0.00001. HIFU combined with GnRH-a and LNG-IUS on menstrual score at 3 months was significantly different higher heterogeneity with P < 0.00001 (I = 100% WMD 56.23 [16.01, 96.45]) with statistical significance P = 0.006. At 6 months there was significantly different higher heterogeneity P < 0.00001 (I = 99% WMD 93.86 [64.15, 123.57]) with statistical significance P < 0.00001. At 12 months there was significantly different higher heterogeneity P < 0.00001 (I = 99% WMD 97.13 [67.81, 126.46]) with statistical significance P < 0.00001 compared to treatments with only HIFU and HIFU combined with GnRH-a. HIFU combined with GnRH-a and LNG-IUS treatment is more effective than only HIFU monotherapy and HIFU combined with GnRH-a.
比较高强度聚焦超声(HIFU)、HIFU联合促性腺激素释放激素激动剂(GnRH-a)以及HIFU联合GnRH-a和左炔诺孕酮宫内节育系统(LNG-IUS)治疗子宫腺肌病的疗效。我们在科学Direct、考克兰图书馆、威利在线图书馆、PubMed和泰勒·弗朗西斯进行了文献检索。共识别出471篇文章,12篇纳入系统评价,其中11篇经定量评估合格纳入荟萃分析。使用3、6、12、24个月时的痛经和月经评分评估三种治疗方案的疗效。在这三种方案中,HIFU联合GnRH-a和LNG-IUS的治疗效果最佳。在6个月时痛经评分方面,异质性显著更高,P<0.00001(I=100%,加权均数差21.44[6.34,36.53]),统计学显著性P=0.005。在12个月时,异质性显著更高,P<0.00001(I=100%,加权均数差23.47[6.00,40.94]),统计学显著性P<0.008。在24个月时,异质性显著更高,P<0.0005(I=92%,加权均数差6.05[4.81,7.30]),统计学显著性P<0.00001。HIFU联合GnRH-a和LNG-IUS在3个月时月经评分的异质性显著更高,P<0.00001(I=100%,加权均数差56.23[16.01,96.45]),统计学显著性P=